Guest guest Posted April 5, 1999 Report Share Posted April 5, 1999 Hi Jodi -- I talked to a patient of Dr. Salvato's who said that the combination of oral interferon and glutathione had raised her natural killer cell count back to normal. My count was normal to begin with. You might also consider giving your pharmacist the number of Catchings Pharmacy -- 800-356-1620 -- so he can find out how mixes the stuff there. His dosages are pretty accurate. I've heard that interferon tends to clump up when you dilute it, so using Salvato's method, where you make one big bottle of the stuff and then withdraw individual doses as you take them, might cause the dosages to be inaccurate. Good luck, and thanks for sharing! Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 6, 1999 Report Share Posted April 6, 1999 > I talked to a patient of Dr. Salvato's who said that the combination of oral > interferon and glutathione had raised her natural killer cell count back to > normal. My count was normal to begin with. The *COUNT* is virtually meaningless. Its the *FUNCTION* that matters. There are many people with terminal cancer, on death's doorstep with normal NK counts, but their NK function is undetectable. It doesn't matter how many NK cells you have if they are " turned off " and are not doing their job. My NK count was perfectally " normal " , my NK function was undetectable. I was suprised that as " progressive " as dr. Bihari is, he does an NK count instead of NK function. This is a pointless waste of money. Patti -- Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 7, 1999 Report Share Posted July 7, 1999 Brown wrote: > From: Brown <pbrown@...> > > Picked up my oral interferon alpha lozenges today. Took 1/2 of one about > 2:15 p.m.[approx 75 I.U.] Noticed phlegm starting to trickle down my > throat and throat a bit tender within 20 minutes. Will let you know how > it goes. > Brown Congratulations , hope the interferon works for you! Do you have CFS and/or FMS??? How long have you been ill??? Do you know if the lozenges are available to us here in the US yet? How does the stuff taste????? Good luck to you and keep us posted on your progress! Marcia Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 8, 1999 Report Share Posted July 8, 1999 Hi , I certainly do wish you well on the interferon and hope it helps you tremendously. Actually, I wanted to try it, too, and when I went to see Cheney (my CFIDS doc) in April, I asked him about it. But he didn't seem to support the idea. Maybe because he suspects that I'm in Phase II of CFIDS and I need to have a different treatment approach or something, I don't know... At any rate, he started talking about the difference between oral interferon and (dare I mention the word?) ampligen. When I asked him exactly what WAS the difference was between the two medicines, Cheney said that interferon worked like a " drug " and had an effect on everything and ampligen just worked on a problem if it to " be fixed. " He used the analogy of blood pressure medicine. He said interferon is like blood pressure medicine. A blood pressure pill lowers your blood pressure whether you need for your blood pressure to be lowered or not. Ampligen, on the other hand, would be a type of " blood pressure pill " that would just lower your blood pressure if you needed to have your blood pressure lowered. I think that is why some people on interferon have gotten sick on Interferon. It does everything, instead of just regulating the defective RNase-L enzyme. However, it HAS worked wonderfully for some of the folks on this list and hopefully it'll do great things for you, too! Once again, good luck! Do let us know how you progress. I'd like to tell Cheney. Brown wrote: > > From: Brown <pbrown@...> > > Picked up my oral interferon alpha lozenges today. Took 1/2 of one about > 2:15 p.m.[approx 75 I.U.] Noticed phlegm starting to trickle down my > throat and throat a bit tender within 20 minutes. Will let you know how > it goes. > Brown > > --------------------------- Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 8, 1999 Report Share Posted July 8, 1999 My MD read through all the Ampligen literature and concluded that Ampligen is just " a second generation gamma globulin. " Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 8, 1999 Report Share Posted July 8, 1999 This I don't know about, as I didn't ask Cheney about gamma globulin. But in his DFW Seminar he showed slides of people on whom he had run ampligen tests and you could actually SEE the defective RNase-L enzyme being corrected. Actually, it was quite interesting to see. Please note here that I am neither pro or con on the Ampligen issue. In fact, right now I am taking Immunocal. SWNGDABOAT@... wrote: > > From: SWNGDABOAT@... > > My MD read through all the Ampligen literature and concluded that Ampligen is > just " a second generation gamma globulin. " > > --------------------------- Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 8, 1999 Report Share Posted July 8, 1999 Its my understanding that Ampligen is a second generation INTERFERON, not gamma globulin. Marcia allan moore wrote: > From: allan moore <afmoore1@...> > > This I don't know about, as I didn't ask Cheney about gamma globulin. > But in his DFW Seminar he showed slides of people on whom he had run > ampligen tests and you could actually SEE the defective RNase-L enzyme > being corrected. Actually, it was quite interesting to see. Please > note here that I am neither pro or con on the Ampligen issue. In fact, > right now I am taking Immunocal. > > SWNGDABOAT@... wrote: > > > > From: SWNGDABOAT@... > > > > My MD read through all the Ampligen literature and concluded that Ampligen is > > just " a second generation gamma globulin. " > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 13, 2000 Report Share Posted June 13, 2000 Sorry I have not noticed previous posts - how does one get oral interferon - what do you " suggest " to your doc' to get it, and who is particularly suited for it - any PWC? I have read about it, but seem to remember it had some risks? Anyone help with this, thanks? M- Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 26, 2005 Report Share Posted September 26, 2005 Amarillo Biosciences to Provide Oral Interferon for MD Clinical Trial in Patients With Bone Marrow Disorders Enrollment at MD Cancer Center Open AMARILLO, TX -- (MARKET WIRE) -- 09/22/2005 -- Amarillo Biosciences, Inc. (ABI) (OTC BB: AMAR) today announced that a study to test low dose oral interferon alpha in forty patients with rare bone marrow proliferative disorders is now open to enrollment. Amarillo Biosciences filed the Investigational New Drug Application with the FDA, and, in conjunction with principal investigator Srdan Verstovsek, MD, PhD, Assistant Professor, Myeloproliferative Disorders Program Leader, University of Texas, MD Cancer Center, Houston, Texas, helped to develop the protocol for the clinical trial. In addition, Amarillo Biosciences will provide the low dose oral interferon that will be used in the study. Twenty patients, each with either polycythemia vera (PV) or primary thrombocythemia (ET), will be given low dose oral interferon alpha daily as a treatment to relieve the signs and symptoms associated with these disorders. This study is open to patients not previously exposed to interferon preparations. Potential participants should not be currently taking other medications to control their blood cell count. PV and ET are stem cell disorders considered to be incurable. Treatment is directed at reducing morbidity and preventing life-threatening complications. The clinical course of both ET and PV are characterized by vasomotor disturbances (headaches, dizziness), acral dysesthesia (impaired sensations in limbs, fingers, ears), erythromelalgia (diffused redness and atrophy of skin on legs), visual symptoms, thrombohemorrahagic (inappropriate clotting) events, and the risk of transformation into acute myeloid leukemia (AML) or fibrosis of the bone marrow (myelofibrosis). Treatment efforts in ET strive to reduce clotting events in patients at high-risk for thrombosis without increasing the intrinsically low risk of developing leukemia. All patients with PV require phlebotomy (drawing blood), with the goal of reducing hematocrit levels (the concentration of red blood cells). This maneuver prolongs survival by decreasing the risk of thrombosis. The goal of therapy in PV is not only to prevent thrombosis, but also to reduce the risk of transformation into AML or myelofibrosis. PV and ET patients interested in enrollment should contact Srdan Verstovsek, MD, PhD, Assistant Professor, Myeloproliferative Disorders Program Leader, University of Texas, MD Cancer Center, Houston, Texas at (713) 792-7305. About Amarillo Biosciences, Inc. Amarillo Biosciences, Inc., is a U.S. biotechnology firm operating in global partnership with the Hayashibara Group, which also holds 20.6% of Amarillo Biosciences shares and has provided over $17.8 million in loans, grants and equity investments. The Company's primary focus is extensive and ongoing R & D into the use of low-dose, orally administered interferon as a treatment for a variety of conditions, including Sjogren's syndrome, Behcet's disease, and opportunistic infections in patients who are HIV positive. In its 20-year history, ABI has invested nearly $37 million to establish oral interferon as a therapeutic agent. The overwhelming majority of those funds were invested in clinical trials in an effort to achieve FDA approval for interferon. Additional information is available on the ABI web site at http://www.amarbio.com/. Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties, including uncertainties related to product development, uncertainties related to the need for regulatory and other government approvals, dependence on proprietary technology, uncertainty of market acceptance of oral interferon or the Company's other product candidates and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. In particular, see "Item 1. Description of Business" of the Company's Form 10-KSB for the year ended December 31, 2004. Investor Relations: Philippe Niemetz WPH Consultants, Ltd. Tel: 800-477-7570 Tel: 212-344-6464 Fax: 212-618-1276 e-mail: Email Contact ph M. Cummins, DVM, PhD Amarillo Biosciences, Inc. Tel: 806-376-1741 x 13 Fax: 806-376-9301 e-mail: Email Contact SOURCE: Amarillo Biosciences, Inc. http://www.marketwire.com/mw/release_html_b1?release_id=95991 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.